(Q86204254)
Statements
C-4 modified sialosides enhance binding to Siglec-2 (CD22): towards potent Siglec inhibitors for immunoglycotherapy (English)
Paul Madge
Tasneem Islam
Ryan Bennett
Hendrik Koliwer-Brandl
Mario Waespy
Mark von Itzstein
25 February 2013